Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-03-10
1993-05-04
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514326, 514396, 514397, 514398, 514399, 514400, 544139, 544337, 546 22, 548111, 548112, A61K 31535, A61K 31415, C07D41314, C07F 928
Patent
active
052082342
ABSTRACT:
Novel compounds having the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as antihypertensive agents.
REFERENCES:
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4582847 (1986-04-01), Furukawa et al.
patent: 4820843 (1989-04-01), Aldrich et al.
patent: 4870186 (1989-09-01), Aldrich et al.
patent: 4874867 (1989-10-01), Aldrich et al.
patent: 4880804 (1989-11-01), Carini et al.
E. R. Squibb & Sons Inc.
Lee Mary C.
McKane Joseph K.
Park Ellen K.
LandOfFree
Substituted imidazole phosphonic and phosphinic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazole phosphonic and phosphinic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazole phosphonic and phosphinic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1975340